Flang (Fludarabine + Cytosine Arabinoside + Novantrone + G-CSF) Induces Partial Remission in Lymphoid Blast Transformation of Ph+ Chronic Myelogenous Leukaemia
作者： Giovanni Martinelli , Nicoletta Testoni , Eliana Zuffa , Giuseppe Visani , Pier Luigi Zinzani
DOI: 10.3109/10428199609051745
关键词:
摘要: The adenine nucleoside analogue, fludarabine phosphate, in combination with cytosine-arabinoside (Ara-C) and granulocyte-colony stimulating factor (G-CSF) (the so called FLAG regimen) has recently ...
informahealthcare.com参考文章(34)
K Bhalla, P Swerdlow, S Grant, Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood. ,vol. 78, pp. 2937- 2944 ,(1991) , 10.1182/BLOOD.V78.11.2937.2937
Avery A. Sandberg, The second International Workshop on Chromosomes in Leukemia Cancer Genetics and Cytogenetics. ,vol. 2, pp. 89- 92 ,(1980) , 10.1016/0165-4608(80)90048-5
R Hehlmann, H Heimpel, J Hasford, HJ Kolb, H Pralle, DK Hossfeld, W Queisser, H Loffler, B Heinze, A Georgii, Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group Blood. ,vol. 82, pp. 398- 407 ,(1993) , 10.1182/BLOOD.V82.2.398.398
G Visani, P Tosi, PL Zinzani, S Manfroi, E Ottaviani, N Testoni, M Clavio, A Cenacchi, B Gamberi, P Carrara, None, FLAG (fludarabine + high-dose cytarabine + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias. Leukemia. ,vol. 8, pp. 1842- 1846 ,(1994)
Sante Tura, Michele Baccarani, Eliana Zuffa, Domenico Russo, Renato Fanin, Alfonso Zaccaria, Mauro Fiacchini, None, Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. The New England Journal of Medicine. ,vol. 330, pp. 820- 825 ,(1994) , 10.1056/NEJM199403243301204
Chrēstos Spyrou Bartsokas, Dimitris Loukopoulos, Genetics of Hematological Disorders ,(1991)
Annette Kemena, Varsha Gandhi, Michael J. Keating, William Plunkett, Fludarabine infusion potentiates arabinosylcytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia. Cancer Research. ,vol. 52, pp. 897- 903 ,(1992)
M J Keating, H Kantarjian, T L Smith, E Estey, R Walters, B Andersson, M Beran, K B McCredie, E J Freireich, Response to salvage therapy and survival after relapse in acute myelogenous leukemia. Journal of Clinical Oncology. ,vol. 7, pp. 1071- 1080 ,(1989) , 10.1200/JCO.1989.7.8.1071
M J Keating, H Kantarjian, S O'Brien, C Koller, M Talpaz, J Schachner, C C Childs, E J Freireich, K B McCredie, Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology. ,vol. 9, pp. 44- 49 ,(1991) , 10.1200/JCO.1991.9.1.44
V Gandhi, E Estey, M J Keating, W Plunkett, Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. Journal of Clinical Oncology. ,vol. 11, pp. 116- 124 ,(1993) , 10.1200/JCO.1993.11.1.116